Broadleaf Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Broadleaf Partners, LLC

$403 Million
Q4 2024

A detailed history of Broadleaf Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Broadleaf Partners, LLC holds 16,923 shares of VRTX stock, worth $8.52 Million. This represents 1.69% of its overall portfolio holdings.

Number of Shares

16,923

Previous 17,124 1.17%

Holding current value

$8.52 Million

Previous $7.96 Million 14.44%

% of portfolio

1.69%

Previous 1.94%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$396.64 - $516.74 $79,724 - $103,864	-201 Reduced 1.17%	16,923 $6.81 Million
Q3 2024 Nov 12, 2024	SELL	$460.0 - $505.78 $38,640 - $42,485	-84 Reduced 0.49%	17,124 $7.96 Million
Q2 2024 Aug 12, 2024	SELL	$392.81 - $485.53 $44,780 - $55,350	-114 Reduced 0.66%	17,208 $8.07 Million
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $7.06 Million - $7.73 Million	17,322 New	17,322 $7.24 Million
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $21,266 - $25,462	-62 Reduced 0.35%	17,403 $7.08 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $44,977 - $48,207	-133 Reduced 0.76%	17,465 $6.07 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $5.53 Million - $6.19 Million	17,598 New	17,598 $6.19 Million
Q4 2021 Feb 09, 2022	SELL	$177.01 - $223.45 $6.8 Million - $8.59 Million	-38,424 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$181.39 - $202.99 $289,317 - $323,769	1,595 Added 4.33%	38,424 $6.97 Million
Q2 2021 Jul 15, 2021	BUY	$187.49 - $221.1 $845,579 - $997,161	4,510 Added 13.95%	36,829 $7.43 Million
Q1 2021 Apr 23, 2021	BUY	$207.02 - $241.31 $296,866 - $346,038	1,434 Added 4.64%	32,319 $6.95 Million
Q4 2020 Feb 24, 2021	BUY	$207.01 - $276.09 $12,834 - $17,117	62 Added 0.2%	30,885 $7.3 Million
Q3 2020 Oct 23, 2020	BUY	$255.65 - $303.1 $1.26 Million - $1.49 Million	4,925 Added 19.02%	30,823 $8.39 Million
Q2 2020 Aug 04, 2020	SELL	$225.48 - $295.8 $694,252 - $910,768	-3,079 Reduced 10.63%	25,898 $7.52 Million
Q1 2020 May 05, 2020	SELL	$199.77 - $247.81 $39,554 - $49,066	-198 Reduced 0.68%	28,977 $6.9 Million
Q4 2019 Jan 31, 2020	SELL	$166.71 - $223.91 $26,173 - $35,153	-157 Reduced 0.54%	29,175 $6.39 Million
Q3 2019 Oct 21, 2019	BUY	$166.23 - $187.09 $1.01 Million - $1.14 Million	6,104 Added 26.28%	29,332 $4.97 Million
Q2 2019 Jul 19, 2019	BUY	$164.61 - $190.37 $80,165 - $92,710	487 Added 2.14%	23,228 $4.26 Million
Q1 2019 Apr 10, 2019	SELL	$163.73 - $194.7 $14,899 - $17,717	-91 Reduced 0.4%	22,741 $4.18 Million
Q1 2019 Apr 09, 2019	BUY	$163.73 - $194.7 $180,103 - $214,170	1,100 Added 5.06%	22,832 $4.31 Million
Q4 2018 Jan 15, 2019	BUY	$151.91 - $192.21 $396,333 - $501,475	2,609 Added 13.64%	21,732 $3.6 Million
Q3 2018 Oct 12, 2018	SELL	$167.73 - $192.74 $41,261 - $47,414	-246 Reduced 1.27%	19,123 $3.69 Million
Q2 2018 Aug 07, 2018	SELL	$145.72 - $169.96 $2.82 Million - $3.29 Million	-19,369 Reduced 50.0%	19,369 $3.29 Million
Q2 2018 Jul 17, 2018	BUY	$145.72 - $169.96 $5.64 Million - $6.58 Million	38,738 New	38,738 $6.58 Million

Others Institutions Holding VRTX

# of Institutions

1,764

Shares Held

228M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Broadleaf Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Broadleaf Partners, LLC with notifications on news.

Account

Broadleaf Partners, LLC Vertex Pharmaceuticals Inc Transaction History